179 related articles for article (PubMed ID: 37210446)
1. Major Postoperative Complications Limit Adjuvant Therapy Administration in Patients Undergoing Pancreatoduodenectomy for Distal Cholangiocarcinoma or Pancreatic Ductal Adenocarcinoma.
Macfie R; Berger Y; Liu H; Li T; Imtiaz S; Ang C; Sarpel U; Hiotis S; Labow D; Golas B; Cohen NA
Ann Surg Oncol; 2023 Aug; 30(8):5027-5034. PubMed ID: 37210446
[TBL] [Abstract][Full Text] [Related]
2. Long-term Outcomes After Laparoscopic, Robotic, and Open Pancreatoduodenectomy for Distal Cholangiocarcinoma: An International Propensity Score-matched Cohort Study.
Uijterwijk BA; Lemmers DHL; Bolm L; Luyer M; Koh YX; Mazzola M; Webber L; Kazemier G; Bannone E; Ramaekers M; Ielpo B; Wellner U; Koek S; Giani A; Besselink MG; Abu Hilal M;
Ann Surg; 2023 Sep; 278(3):e570-e579. PubMed ID: 36730852
[TBL] [Abstract][Full Text] [Related]
3. Serious complications of pancreatoduodenectomy correlate with lower rates of adjuvant chemotherapy: Results from the recurrence after Whipple's (RAW) study.
Russell TB; Labib PL; Ausania F; Pando E; Roberts KJ; Kausar A; Mavroeidis VK; Marangoni G; Thomasset SC; Frampton AE; Lykoudis P; Maglione M; Alhaboob N; Bari H; Smith AM; Spalding D; Srinivasan P; Davidson BR; Bhogal RH; Croagh D; Dominguez I; Thakkar R; Gomez D; Silva MA; Lapolla P; Mingoli A; Porcu A; Shah NS; Hamady ZZR; Al-Sarrieh B; Serrablo A; ; ; ; ; ; ; ; ; Aroori S
Eur J Surg Oncol; 2023 Sep; 49(9):106919. PubMed ID: 37330348
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of postoperative complication after pancreatoduodenectomy for pancreatic adenocarcinoma stratified by the resectability status.
Kondo N; Murakami Y; Uemura K; Nakagawa N; Okada K; Takahashi S; Sueda T
J Surg Oncol; 2018 Dec; 118(7):1105-1114. PubMed ID: 29878355
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes after pancreatoduodenectomy for ampullary cancer: The influence of the histological subtypes and comparison with the other periampullary neoplasms.
Nappo G; Galvanin J; Gentile D; Capretti G; Pulvirenti A; Bozzarelli S; Rimassa L; Spaggiari P; Carrara S; Petitti T; Gavazzi F; Zerbi A
Pancreatology; 2021 Aug; 21(5):950-956. PubMed ID: 33795194
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of laparoscopic versus open pancreatoduodenectomy following neoadjuvant chemotherapy for borderline resectable pancreatic cancer: a retrospective cohort study.
Li Z; Zhuo Q; Li B; Liu M; Chen C; Shi Y; Xu W; Liu W; Ji S; Yu X; Xu X
World J Surg Oncol; 2024 Jan; 22(1):1. PubMed ID: 38169384
[TBL] [Abstract][Full Text] [Related]
7. Postoperative infectious complications worsen oncologic outcomes following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Khachfe HH; Hammad AY; AlMasri S; Nassour I; ElAsmar R; Liu H; de Silva A; Kraftician J; Lee KK; Zureikat AH; Paniccia A
J Surg Oncol; 2024 May; 129(6):1097-1105. PubMed ID: 38316936
[TBL] [Abstract][Full Text] [Related]
8. Intra-pancreatic distal cholangiocarcinoma and pancreatic ductal adenocarcinoma: a common short and long-term prognosis?
Guilbaud T; Girard E; Lemoine C; Schlienger G; Alao O; Risse O; Berdah S; Chirica M; Moutardier V; Birnbaum DJ
Updates Surg; 2021 Apr; 73(2):439-450. PubMed ID: 33486711
[TBL] [Abstract][Full Text] [Related]
9. Distal Cholangiocarcinoma and Pancreas Adenocarcinoma: Are They Really the Same Disease? A 13-Institution Study from the US Extrahepatic Biliary Malignancy Consortium and the Central Pancreas Consortium.
Ethun CG; Lopez-Aguiar AG; Pawlik TM; Poultsides G; Idrees K; Fields RC; Weber SM; Cho C; Martin RC; Scoggins CR; Shen P; Schmidt C; Hatzaras I; Bentrem D; Ahmad S; Abbott D; Kim HJ; Merchant N; Staley CA; Kooby DA; Maithel SK
J Am Coll Surg; 2017 Apr; 224(4):406-413. PubMed ID: 28017812
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of pancreatic fistula and postoperative complications after pancreaticoduodenectomy in patients with pancreatic ductal adenocarcinoma.
Neeman U; Lahat G; Goykhman Y; Geva R; Peles-Avraham S; Nachmany I; Nakache R; Klausner JM; Lubezky N
Surgeon; 2020 Feb; 18(1):24-30. PubMed ID: 31466841
[TBL] [Abstract][Full Text] [Related]
11. Impact of adjuvant chemotherapy after pancreaticoduodenectomy for distal cholangiocarcinoma: a propensity score analysis from a French multicentric cohort.
Bergeat D; Turrini O; Courtin-Tanguy L; Truant S; Darnis B; Delpero JR; Mabrut JY; Regenet N; Sulpice L
Langenbecks Arch Surg; 2018 Sep; 403(6):701-709. PubMed ID: 30112638
[TBL] [Abstract][Full Text] [Related]
12. The role of preoperative therapy prior to pancreatoduodenectomy for distal cholangiocarcinoma.
Cloyd JM; Prakash L; Vauthey JN; Aloia TA; Chun YS; Tzeng CW; Kim MP; Lee JE; Katz MHG
Am J Surg; 2019 Jul; 218(1):145-150. PubMed ID: 30224070
[TBL] [Abstract][Full Text] [Related]
13. Minimally invasive versus open pancreatoduodenectomy for pancreatic ductal adenocarcinoma: Individual patient data meta-analysis of randomized trials.
Uijterwijk BA; Wei K; Kasai M; Ielpo B; Hilst JV; Chinnusamy P; Lemmers DHL; Burdio F; Senthilnathan P; Besselink MG; Abu Hilal M; Qin R
Eur J Surg Oncol; 2023 Aug; 49(8):1351-1361. PubMed ID: 37076411
[TBL] [Abstract][Full Text] [Related]
14. Survival benefit with adjuvant radiotherapy after resection of distal cholangiocarcinoma: A propensity-matched National Cancer Database analysis.
Kamarajah SK; Bednar F; Cho CS; Nathan H
Cancer; 2021 Apr; 127(8):1266-1274. PubMed ID: 33320344
[TBL] [Abstract][Full Text] [Related]
15. Impact of preoperative statin medication on long-term outcomes after pancreatoduodenectomy for ductal adenocarcinoma: an international multicentric cross-sectional study.
Joliat GR; Gaspar-Figueiredo S; Labgaa I; Vrochides D; Perinel J; Adham M; Demartines N; Schäfer M
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17007-17014. PubMed ID: 37740766
[TBL] [Abstract][Full Text] [Related]
16. Robotic approach mitigates the effect of major complications on survival after pancreaticoduodenectomy for periampullary cancer.
Meyyappan T; Wilson GC; Zeh HJ; Hogg ME; Lee KK; Zureikat AH; Paniccia A
Surg Endosc; 2023 Feb; 37(2):1181-1187. PubMed ID: 36163566
[TBL] [Abstract][Full Text] [Related]
17. Complete circumferential lymphadenectomy around the superior mesenteric artery with preservation of nerve plexus reduces locoregional recurrence after pancreatoduodenectomy for resectable pancreatic ductal adenocarcinoma.
Hirono S; Kawai M; Okada KI; Miyazawa M; Kitahata Y; Kobayashi R; Hayami S; Ueno M; Yamaue H
Eur J Surg Oncol; 2021 Oct; 47(10):2586-2594. PubMed ID: 34127329
[TBL] [Abstract][Full Text] [Related]
18. A Delay in Adjuvant Therapy Is Associated With Worse Prognosis Only in Patients With Transitional Circulating Tumor Cells After Resection of Pancreatic Ductal Adenocarcinoma.
Javed AA; Floortje van Oosten A; Habib JR; Hasanain A; Kinny-Köster B; Gemenetzis G; Groot VP; Ding D; Cameron JL; Lafaro KJ; Burns WR; Burkhart RA; Yu J; He J; Wolfgang CL
Ann Surg; 2023 Jun; 277(6):866-872. PubMed ID: 36111839
[TBL] [Abstract][Full Text] [Related]
19. The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma.
Ruess DA; Makowiec F; Chikhladze S; Sick O; Riediger H; Hopt UT; Wittel UA
BMC Surg; 2015 Nov; 15():123. PubMed ID: 26615588
[TBL] [Abstract][Full Text] [Related]
20. Outcomes in patients with pancreatic ductal adenocarcinoma (PDAC) undergoing robotic (RPD) or open pancreaticoduodenectomies (OPD): a propensity score-weighted survival analysis.
Mejia A; Shah J; Vivian E; Beard R; Acharya P; Gutierrez JCB
J Robot Surg; 2023 Jun; 17(3):1085-1096. PubMed ID: 36581740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
